D. Yazilitas Et Al. , "Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer: A retrospective study of the Anatolian Society of Medical Oncology," Asian Pacific Journal of Cancer Prevention , vol.16, no.4, pp.1471-1477, 2015
Yazilitas, D. Et Al. 2015. Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer: A retrospective study of the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention , vol.16, no.4 , 1471-1477.
Yazilitas, D., ŞENDUR, M. A. N., Karaca, H., Ozdemir, N., AKSOY, S., Berk, V., ... Yazici, O.(2015). Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer: A retrospective study of the Anatolian Society of Medical Oncology. Asian Pacific Journal of Cancer Prevention , vol.16, no.4, 1471-1477.
Yazilitas, Dogan Et Al. "Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer: A retrospective study of the Anatolian Society of Medical Oncology," Asian Pacific Journal of Cancer Prevention , vol.16, no.4, 1471-1477, 2015
Yazilitas, Dogan Et Al. "Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer: A retrospective study of the Anatolian Society of Medical Oncology." Asian Pacific Journal of Cancer Prevention , vol.16, no.4, pp.1471-1477, 2015
Yazilitas, D. Et Al. (2015) . "Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer: A retrospective study of the Anatolian Society of Medical Oncology." Asian Pacific Journal of Cancer Prevention , vol.16, no.4, pp.1471-1477.
@article{article, author={Dogan Yazilitas Et Al. }, title={Efficacy of dose dense doxorubicin and cyclophosphamide followed by paclitaxel versus conventional dose doxorubicin, cyclophosphamide followed by paclitaxel or docetaxel in patients with node-positive breast cancer: A retrospective study of the Anatolian Society of Medical Oncology}, journal={Asian Pacific Journal of Cancer Prevention}, year=2015, pages={1471-1477} }